Journal of Molecular Neuroscience

, Volume 67, Issue 4, pp 511–533 | Cite as

Insights into the Potential Role of Mercury in Alzheimer’s Disease

  • Geir BjørklundEmail author
  • Alexey A. Tinkov
  • Maryam Dadar
  • Md. Mostafizur Rahman
  • Salvatore Chirumbolo
  • Anatoly V. Skalny
  • Margarita G. Skalnaya
  • Boyd E. Haley
  • Olga P. Ajsuvakova
  • Jan Aaseth


Mercury (Hg), which is a non-essential element, is considered a highly toxic pollutant for biological systems even when present at trace levels. Elevated Hg exposure with the growing release of atmospheric pollutant Hg and rising accumulations of mono-methylmercury (highly neurotoxic) in seafood products have increased its toxic potential for humans. This review aims to highlight the potential relationship between Hg exposure and Alzheimer’s disease (AD), based on the existing literature in the field. Recent reports have hypothesized that Hg exposure could increase the potential risk of developing AD. Also, AD is known as a complex neurological disorder with increased amounts of both extracellular neuritic plaques and intracellular neurofibrillary tangles, which may also be related to lifestyle and genetic variables. Research reports on AD and relationships between Hg and AD indicate that neurotransmitters such as serotonin, acetylcholine, dopamine, norepinephrine, and glutamate are dysregulated in patients with AD. Many researchers have suggested that AD patients should be evaluated for Hg exposure and toxicity. Some authors suggest further exploration of the Hg concentrations in AD patients. Dysfunctional signaling pathways in AD and Hg exposure appear to be interlinked with some driving factors such as arachidonic acid, homocysteine, dehydroepiandrosterone (DHEA) sulfate, hydrogen peroxide, glucosamine glycans, glutathione, acetyl-L carnitine, melatonin, and HDL. This evidence suggests the need for a better understanding of the relationship between AD and Hg exposure, and potential mechanisms underlying the effects of Hg exposure on regional brain functions. Also, further studies evaluating brain functions are needed to explore the long-term effects of subclinical and untreated Hg toxicity on the brain function of AD patients.


Alzheimer’s disease Mercury β-Amyloid Tau 



The publication was prepared with the support of the RUDN University Program 5-100.


  1. Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U (2016) Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation. Biometals 29:827–839. Google Scholar
  2. Abram Z, Korossy S (1994) Presynaptic and postsynaptic effects of mercuric ions on Guinea-pig ileum longitudinal muscle strip preparation. Neurochem Res 19:1467–1472. Google Scholar
  3. Aguado A, Galán M, Zhenyukh O, Wiggers GA, Roque FR, Redondo S, Peçanha F, Martín A, Fortuño A, Cachofeiro V (2013) Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. Toxicol Appl Pharmacol 268:188–200. Google Scholar
  4. Alattia J-R, Kuraishi T, Dimitrov M, Chang I, Lemaitre B, Fraering PC (2011) Mercury is a direct and potent γ-secretase inhibitor affecting notch processing and development in drosophila. FASEB J 25:2287–2295. Google Scholar
  5. Alexandrov PN, Pogue AI, Lukiw WJ (2018) Synergism in aluminum and mercury neurotoxicity. Integr Food Nutr Metab 5(3).
  6. Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, Visconti A, Brescianini S, Sepe Monti M, Forte G, Stanzione P, Bocca B, Bomboi G, D’Ippolito C, Annibali V, Salvetti M, Sancesario G (2007) Serum chemical elements and oxidative status in Alzheimer’s disease, Parkinson disease and multiple sclerosis. Neurotoxicology 28:450–456. Google Scholar
  7. Alkadhi KA, Dao AT (2018) Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease. Mol Cell Neurosci 86:25–29. Google Scholar
  8. Allen JW, Mutkus LA, Aschner M (2001) Mercuric chloride, but not methylmercury, inhibits glutamine synthetase activity in primary cultures of cortical astrocytes. Brain Res 891:148–157. Google Scholar
  9. Ally A, Buist R, Mills P, Reuhl K (1993) Effects of methylmercury and trimethyltin on cardiac, platelet, and aorta eicosanoid biosynthesis and platelet serotonin release. Pharmacol Biochem Behav 44:555–563. Google Scholar
  10. Alzheimer A (1906) Uber einen eigenartigen schweren Er Krankungsprozeb der Hirnrinde. Neurologisches Centralblatt 23:1129–1136Google Scholar
  11. Arnhold F, Gührs K-H, von Mikecz A (2015) Amyloid domains in the cell nucleus controlled by nucleoskeletal protein Lamin B1 reveal a new pathway of mercury neurotoxicity. PeerJ 3:e754. Google Scholar
  12. Arrifano GPF, de Oliveira MA, Souza-Monteiro JR, Paraense RSO, Ribeiro-dos-Santos A, dos Santos Vieira JR, da Costa Silva AL, da Silva FM, de Matos MB (2018) Role for apolipoprotein e in neurodegeneration and mercury intoxication. Front Biosci (elite edition) 10:229–241. Google Scholar
  13. Aschner M, Yao CP, Allen JW, Tan KH (2000) Methylmercury alters glutamate transport in astrocytes. Neurochem Int 37:199–206. Google Scholar
  14. Aschner M, Syversen T, Souza D, JBTd R, Farina M (2007) Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res 40:285–291. Google Scholar
  15. Ballester F, Iñiguez C, Murcia M, Guxens M, Basterretxea M, Rebagliato M, Vioque J, Lertxundi A, Fernandez-Somoano A, Tardon A (2018) Prenatal exposure to mercury and longitudinally assessed fetal growth: relation and effect modifiers. Environ Res 160:97–106. Google Scholar
  16. Baraldi M, Zanoli P, Tascedda F, Blom JM, Brunello N (2002) Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure. Environ Health Perspect 110:855. Google Scholar
  17. Basu N, Stamler CJ, Loua KM, Chan HM (2005) An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellum. Toxicol Appl Pharmacol 205:71–76. Google Scholar
  18. Basu N, Kwan M, Man Chan H (2006) Mercury but not organochlorines inhibits muscarinic cholinergic receptor binding in the cerebrum of ringed seals (Phoca hispida). J Toxicol Environ Health A 69:1133–1143. Google Scholar
  19. Basu N, Clarke E, Green A, Calys-Tagoe B, Chan L, Dzodzomenyo M, Fobil J, Long RN, Neitzel RL, Obiri S (2015) Integrated assessment of artisanal and small-scale gold mining in Ghana—part 1: human health review. Int J Environ Res Public Health 12:5143–5176. Google Scholar
  20. Basun H, Forssell L, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer’s disease. J Neural Transm Park Dis Dement Sect 3:231–258Google Scholar
  21. Bavec Š, Gosar M, Miler M, Biester H (2017) Geochemical investigation of potentially harmful elements in household dust from a mercury-contaminated site, the town of Idrija (Slovenia). Environ Geochem Health 39:443–465. Google Scholar
  22. Bedir Findik R, Celik HT, Ersoy AO, Tasci Y, Moraloglu O, Karakaya J (2016) Mercury concentration in maternal serum, cord blood, and placenta in patients with amalgam dental fillings: effects on fetal biometric measurements. J Matern Fetal Neonatal Med 29:3665–3669. Google Scholar
  23. Bencko V, Wagner V, Wagnerova M, Ondrejcak V (1990) Immunological profiles in workers occupationally exposed to inorganic mercury. J Hyg Epidemiol Microbiol Immunol 34:9–15Google Scholar
  24. Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, Lopez-Rodriguez ML (2014) Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease. J Med Chem 57:7160–7181Google Scholar
  25. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A (2000) Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel J Am Geriatr Soc 48:1285–1291. Google Scholar
  26. Bjørklund G (1991) Mercury as a potential source for the etiology of Alzheimer’s disease. Trace Elem Med 8:208–208Google Scholar
  27. Bjørklund G (2015) Selenium as an antidote in the treatment of mercury intoxication. Biometals 28:605–614. Google Scholar
  28. Bjørklund G, Dadar M, Mutter J, Aaseth J (2017a) The toxicology of mercury: current research and emerging trends. Environ Res 159:545–554. Google Scholar
  29. Bjørklund G, Aaseth J, Ajsuvakova OP, Nikonorov AA, Skalny AV, Skalnaya MG, Tinkov AA (2017b) Molecular interaction between mercury and selenium in neurotoxicity. Coord Chem Rev 332:30–37. Google Scholar
  30. Bjørklund G, Mutter J, Aaseth J (2017c) Metal chelators and neurotoxicity: lead, mercury, and arsenic. Arch Toxicol 91:3787-3797.
  31. Bjørklund G, Bengtsson U, Chirumbolo S, Kern JK (2017d) Concerns about environmental mercury toxicity: do we forget something else? Environ Res 152:514–516. Google Scholar
  32. Bjørklund G, Chirumbolo S, Geier DA, Kern JK, Geier MR (2017e) Histone deacetylase inhibitors, thimerosal, and autism spectrum disorder. Environ Res 156:843–844. Google Scholar
  33. Bjørklund G, Lindh U, Aaseth J, Mutter J, Chirumbolo S (2019) Mercury in dental amalgams: a great concern for clinical toxicology in developing countries? J Trace Elem Med Biol 51:9–11. Google Scholar
  34. Black FJ, Bokhutlo T, Somoxa A, Maethamako M, Modisaemang O, Kemosedile T, Cobb-Adams C, Mosepele K, Chimbari M (2011) The tropical African mercury anomaly: lower than expected mercury concentrations in fish and human hair. Sci Total Environ 409:1967–1975. Google Scholar
  35. Black P, Richard M, Rossin R, Telmer K (2017) Assessing occupational mercury exposures and behaviours of artisanal and small-scale gold miners in Burkina Faso using passive mercury vapour badges. Environ Res 152:462–469. Google Scholar
  36. Bodienkova G, Boklazhenko E (2017) Relationship between cytokine concentrations and the level of antibodies to neuronal proteins as dependent on the severity of mercury neurotoxicity. Hum Physiol 43:334–338. Google Scholar
  37. Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, Fülöp T (2015) β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology 16:85–98. Google Scholar
  38. Bradley-Whitman MA, Lovell MA (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Archives of Toxicology 89(7):1035–1044Google Scholar
  39. Bourgade K, Le Page A, Bocti C, Witkowski JM, Dupuis G, Frost EH, Fülöp T Jr (2016) Protective effect of amyloid-β peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis 50:1227–1241. Google Scholar
  40. Breteler MM, Claus JJ, van Duijn CM, Launer LJ, Hofman A (1992) Epidemiology of Alzheimer’s disease. Epidemiol Rev 14:59–82. Google Scholar
  41. Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert J, Bettens K, Le Bastard N, Pasquier F, Montoya AG, Peeters K, Mattheijssens M (2012) Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry 17:223. Google Scholar
  42. Burk RF, Hill KE (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 1790:1441–1447. Google Scholar
  43. Cai Z, Hussain MD, Yan L-J (2014) Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease. Int J Neurosci 124:307–321. Google Scholar
  44. Caito SW, Milatovic D, Hill KE, Aschner M, Burk RF, Valentine WM (2011) Progression of neurodegeneration and morphologic changes in the brains of juvenile mice with selenoprotein P deleted. Brain Res 1398:1–12. Google Scholar
  45. Calabrese EJ, Baldwin LA (2003) Toxicology rethinks its central belief. Nature 421:691. Google Scholar
  46. Calabrese EJ, Iavicoli I, Calabrese V, Cory-Slechta DA, Giordano J (2018) Elemental mercury neurotoxicity and clinical recovery of function: a review of findings, and implications for occupational health. Environ Res 163:134–148. Google Scholar
  47. Cao B, Lv W, Jin S, Tang J, Wang S, Zhao H, Guo H, Su J, Cao X (2013) Degeneration of peripheral nervous system in rats experimentally induced by methylmercury intoxication. Neurol Sci 34:663–669. Google Scholar
  48. Cassano T, Pace L, Bedse G, Michele Lavecchia A, De Marco F, Gaetani S, Serviddio G (2016) Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration. Curr Alzheimer Res 13:185–197. Google Scholar
  49. Chakraborty P (2017) Mercury exposure and Alzheimer’s disease in India—an imminent threat? Sci Total Environ 589:232–235. Google Scholar
  50. Chan MC, Bautista E, Alvarado-Cruz I, Quintanilla-Vega B, Segovia J (2017) Inorganic mercury prevents the differentiation of SH-SY5Y cells: amyloid precursor protein, microtubule associated proteins and ROS as potential targets. J Trace Elem Med Biol 41:119–128. Google Scholar
  51. Cheng JP, Shi W, Lin XY (2005) Effects of mercury contaminated rice from typical chemical plant area in China on nitric oxide changes and c-fos expression of rats brain. J Environ Sci 17:177–180Google Scholar
  52. Cheng J, Yang Y, Ma J, Wang W, Liu X, Sakamoto M, Qu Y, Shi W (2009) Assessing noxious effects of dietary exposure to methylmercury, PCBs and Se coexisting in environmentally contaminated rice in male mice. Environ Int 35:619–625. Google Scholar
  53. Chin-Chan M, Segovia J, Quintanar L, Arcos-López T, Hersh LB, Chow KM, Rodgers DW, Quintanilla-Vega B (2015) Mercury reduces the enzymatic activity of neprilysin in differentiated SH-SY5Y cells. Toxicol Sci 145:128–137. Google Scholar
  54. Choi B, Yeum KJ, Park SJ, Kim KN, Joo NS (2015) Elevated serum ferritin and mercury concentrations are associated with hypertension; analysis of the fourth and fifth Korea national health and nutrition examination survey (KNHANES IV-2, 3, 2008–2009 and V-1, 2010). Environ Toxicol 30:101–108. Google Scholar
  55. Chong JR, Chai YL, Lee JH, Howlett D, Attems J, Ballard CG, Aarsland D, Francis PT, Chen CP, Lai MK (2017) Increased transforming growth factor β2 in the neocortex of Alzheimer’s disease and dementia with Lewy bodies is correlated with disease severity and soluble Aβ 42 load. J Alzheimers Dis 56:157–166. Google Scholar
  56. Cordy P, Veiga MM, Salih I, Al-Saadi S, Console S, Garcia O, Mesa LA, Velásquez-López PC, Roeser M (2011) Mercury contamination from artisanal gold mining in Antioquia, Colombia: the world’s highest per capita mercury pollution. Sci Total Environ 410:154–160. Google Scholar
  57. Cornett CR, Markesbery WR, Ehmann WD (1998a) Imbalances of trace elements related to oxidative damage in Alzheimer’s disease brain. Neurotoxicology 19:339–345Google Scholar
  58. Cornett CR, Ehmann WD, Wekstein DR, Markesbery WR (1998b) Trace elements in Alzheimer’s disease pituitary glands. Biol Trace Elem Res 62:107–114Google Scholar
  59. Crichton RR, Dexter D, Ward RJ (2008) Metal based neurodegenerative diseases—from molecular mechanisms to therapeutic strategies. Coord Chem Rev 252:1189–1199. Google Scholar
  60. Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9:71. Google Scholar
  61. Curtis JT, Chen Y, Buck DJ, Davis RL (2011) Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism? Neurosci Lett 504:40–44. Google Scholar
  62. Dadar M, Adel M, Nasrollahzadeh Saravi H, Fakhri Y (2017) Trace element concentration and its risk assessment in common kilka (Clupeonella cultriventris caspia Bordin, 1904) from southern basin of Caspian Sea. Toxin Rev 36:222–227. Google Scholar
  63. van Dalen JW, Caan MW, van Gool WA, Richard E (2017) Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert. Brain Imaging Behav 11:1707–1719 Google Scholar
  64. Darreh-Shori T (2016) New ligands of choline acetyltransferase as therapeutics and in vivo functional biomarkers in Alzheimer’s disease. Neurobiol Aging:S29.
  65. Dawkins E, Small DH (2014) Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer’s disease. J Neurochem 129:756–769. Google Scholar
  66. Dias C, Lourenço CF, Ferreiro E, Barbosa RM, Laranjinha J, Ledo A (2016) Age-dependent changes in the glutamate-nitric oxide pathway in the hippocampus of the triple transgenic model of Alzheimer’s disease: implications for neurometabolic regulation. Neurobiol Aging 46:84–95. Google Scholar
  67. Dimitrov M, Alattia J-R, Lemmin T, Lehal R, Fligier A, Houacine J, Hussain I, Radtke F, Dal Peraro M, Beher D (2013) Alzheimer’s disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production. Nat Commun 4:2246. Google Scholar
  68. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 29:693–706. Google Scholar
  69. Dórea JG (2017) Low-dose thimerosal in pediatric vaccines: adverse effects in perspective. Environ Res 152:280–293. Google Scholar
  70. Du X, Qiu S, Wang Z, Wang R, Wang C, Tian J, Liu Q (2014) Direct interaction between selenoprotein P and tubulin. Int J Mol Sci 15:10199–10214. Google Scholar
  71. Dursun E, Gezen-Ak D, Hanağası H, Bilgiç B, Lohmann E, Ertan S, Atasoy İL, Alaylıoğlu M, Araz ÖS, Önal B (2015) The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’s disease, mild cognitive impairment or Parkinson’s disease. J Neuroimmunol 283:50–57. Google Scholar
  72. Echeverria D, Woods JS, Heyer NJ, Martin MD, Rohlman DS, Farin FM, Li T (2010) The association between serotonin transporter gene promotor polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. J Toxicol Environ Health A 73:1003–1020. Google Scholar
  73. Ehmann W, Markesbery W, Alauddin M, Hossain T, Brubaker E (1986) Brain trace elements in Alzheimer’s disease. Neurotoxicology 7:195–206Google Scholar
  74. El-Ansary A, Bjørklund G, Tinkov AA, Skalny AV, Al Dera H (2017) Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children. Metab Brain Dis 32:1073–1080. Google Scholar
  75. El-Saeed GS, Abdel Maksoud SA, Bassyouni HT, Raafat J, Agybi MH, Wahby AA, Aly HM (2016) Mercury toxicity and DNA damage in patients with Down syndrome. Med Res J 15:22–26. Google Scholar
  76. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ (2001) Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer’s disease. Genome Res 11:143–151. Google Scholar
  77. Falluel-Morel A, Sokolowski K, Sisti HM, Zhou X, Shors TJ, DiCicco-Bloom E (2007) Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J Neurochem 103:1968–1981. Google Scholar
  78. Farina M, Aschner M (2017) Methylmercury-induced neurotoxicity: focus on pro-oxidative events and related consequences. Adv Neurobiol 18:267–286. Google Scholar
  79. Farina M, Dahm K, Schwalm F, Brusque A, Frizzo M, Zeni G, Souza D, Rocha J (2003) Methylmercury increases glutamate release from brain synaptosomes and glutamate uptake by cortical slices from suckling rat pups: modulatory effect of ebselen. Toxicol Sci 73:135–140. Google Scholar
  80. Farina M, Rocha JB, Aschner M (2011) Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci 89:555–563. Google Scholar
  81. Faro L, Do Nascimento J, Alfonso M, Duran R (2002) Mechanism of action of methylmercury on in vivo striatal dopamine release: possible involvement of dopamine transporter. Neurochem Int 40:455–465. Google Scholar
  82. Fonfría E, Vilaró MT, Babot Z, Rodríguez-Farré E, Sunol C (2005) Mercury compounds disrupt neuronal glutamate transport in cultured mouse cerebellar granule cells. J Neurosci Res 79:545–553. Google Scholar
  83. Fontela YC, Kadavath H, Biernat J, Riedel D, Mandelkow E, Zweckstetter M (2017) Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein tau. Nat Commun 8:1981. Google Scholar
  84. Francis PT (2005) The interplay of neurotransmitters in Alzheimer’s disease. CNS Spectrums 10:6–9. Google Scholar
  85. Franciscato C, Goulart F, Lovatto N, Duarte F, Flores E, Dressler V, Peixoto N, Pereira M (2009) ZnCl2 exposure protects against behavioral and acetylcholinesterase changes induced by HgCl2. Int J Dev Neurosci 27:459–468. Google Scholar
  86. Frasco M, Fournier D, Carvalho F, Guilhermino L (2005) Do metals inhibit acetylcholinesterase (AChE)? Implementation of assay conditions for the use of AChE activity as a biomarker of metal toxicity. Biomarkers 10:360–375. Google Scholar
  87. Frenkel GD, Cain R, Chao ES-E (1985) Exposure of DNA to methyl mercury results in an increase in the rate of its transcription by RNA polymerase II. Biochem Biophys Res Commun 127:849–856. Google Scholar
  88. Fujimura M, Usuki F (2012) Differing effects of toxicants (methylmercury, inorganic mercury, lead, amyloid β, and rotenone) on cultured rat cerebrocortical neurons: differential expression of rho proteins associated with neurotoxicity. Toxicol Sci 126:506–514. Google Scholar
  89. Fujimura M, Usuki F, Sawada M, Takashima A (2009) Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-Jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30:1000–1007. Google Scholar
  90. Fung YK, Meade AG, Rack EP, Blotcky AJ, Claassen JP, Beatty MW, Durham T (1995) Determination of blood mercury concentrations in Alzheimer’s patients. J Toxicol Clin Toxicol 33:243–247. Google Scholar
  91. Fung YK, Meade AG, Rack EP, Blotcky AJ (1997) Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 35:49–54.
  92. Gardner RM, Nyland JF, Evans SL, Wang SB, Doyle KM, Crainiceanu CM, Silbergeld EK (2009) Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro. Environ Health Perspect 117:1932. Google Scholar
  93. Gardner RM, Nyland JF, Silva IA, Ventura AM, de Souza JM, Silbergeld EK (2010) Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environ Res 110:345–354. Google Scholar
  94. Gerhardsson L, Aaseth J (2016) Guidance for clinical treatment of metal poisonings—use and misuse of chelating agents. Chelation therapy in the treatment of metal intoxication. Academic Press, London, pp 313–341Google Scholar
  95. Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 25:508–515. Google Scholar
  96. Giacoppo S, Galuppo M, Calabro RS, D’Aleo G, Marra A, Sessa E, Bua DG, Potorti AG, Dugo G, Bramanti P, Mazzon E (2014) Heavy metals and neurodegenerative diseases: an observational study. Biol Trace Elem Res 161:151–160. Google Scholar
  97. Girek M, Szymański P (2019) Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities. Chem Pap 73:269–289.
  98. Gnanashanmugam G, Balakrishnan R, Somasundaram SP, Parimalam N, Rajmohan P, Pranesh MB (2018) Mercury toxicity following unauthorized siddha medicine intake—a mimicker of acquired neuromyotonia—report of 32 cases. Ann Indian Acad Neurol 21:49–56. Google Scholar
  99. Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL (2014) Homeostasis of metals in the progression of Alzheimer’s disease. Biometals 27:539–549. Google Scholar
  100. Gowert NS, Donner L, Chatterjee M, Eisele YS, Towhid ST, Münzer P, Walker B, Ogorek I, Borst O, Grandoch M (2014) Blood platelets in the progression of Alzheimer’s disease. PLoS One 9:e90523. Google Scholar
  101. Guida N, Laudati G, Mascolo L, Cuomo O, Anzilotti S, Sirabella R, Santopaolo M, Galgani M, Montuori P, Di Renzo G (2016) MC1568 inhibits thimerosal-induced apoptotic cell death by preventing HDAC4 up-regulation in neuronal cells and in rat prefrontal cortex. Toxicol Sci 154:227–240. Google Scholar
  102. Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G (2006) Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol 27:42–45. Google Scholar
  103. Guzzi G, Ronchi A, Barbaro M, Soldarini A, Pigatto PD (2016) Levels of mercury in patient with mercury dental amalgam. Toxicology Letters 258:S113Google Scholar
  104. Hahn L, Kloiber R, Vimy M, Takahashi Y, Lorscheider F (1989) Dental “silver” tooth fillings: a source of mercury exposure revealed by whole-body image scan and tissue analysis. FASEB J 3:2641–2646. Google Scholar
  105. Haley BE (2007) The relationship of the toxic effects of mercury to exacerbation of the medical condition classified as Alzheimer’s disease. Med Veritas 4:1484–1498. Google Scholar
  106. Hanzel CE, Pichet-Binette A, Pimentel LS, Iulita MF, Allard S, Ducatenzeiler A, Do Carmo S, Cuello AC (2014) Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer’s disease. Neurobiol Aging 35:2249–2262. Google Scholar
  107. Hardy J (2017) The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”. FEBS J 284:1040–1044. Google Scholar
  108. Hartley D, Blumenthal T, Carrillo M, DiPaolo G, Esralew L, Gardiner K, Granholm A-C, Iqbal K, Krams M, Lemere C (2015) Down syndrome and Alzheimer's disease: common pathways, common goals. Alzheimers Dement 11:700–709. Google Scholar
  109. Herculano A, Crespo-Lopez M, Lima S, Picanço-Diniz D, Do Nascimento J (2006) Methylmercury intoxication activates nitric oxide synthase in chick retinal cell culture. Braz J Med Biol Res 39:415–418. Google Scholar
  110. Higueras P, Fernández-Martínez R, Esbrí JM, Rucandio I, Loredo J, Ordónez A, Alvarez R (2014) Mercury soil pollution in Spain: a review. In: Jiménez E., Cabañas B, Lefebvre G (eds) Environment, Energy and Climate Change I. Springer, Cham, pp 135–158.
  111. Himi T, Ikeda M, Sato I, Yuasa T, S-i M (1996) Purkinje cells express neuronal nitric oxide synthase after methylmercury administration. Brain Res 718:189–192. Google Scholar
  112. Hock C, Drasch G, Golombowski S, Müller-Spahn F, Willershausen-Zönnchen B, Schwarz P, Hock U, Growdon J, Nitsch R (1998) Increased blood mercury levels in patients with Alzheimer’s disease. J Neural Transm 105:59–68. Google Scholar
  113. Holmes P, James K, Levy L (2009) Is low-level environmental mercury exposure of concern to human health? Sci Total Environ 408:171–182. Google Scholar
  114. Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, Münch G (2007) Lipoic acid as a novel treatment for Alzheimer’s disease and related dementias. Pharmacol Ther 113:154–164. Google Scholar
  115. Homme KG, Kern JK, Haley BE, Geier DA, King PG, Sykes LK, Geier MR (2014) New science challenges old notion that mercury dental amalgam is safe. Biometals 27:19–24. Google Scholar
  116. Hoozemans J, Rozemuller A, Janssen I, De Groot C, Veerhuis R, Eikelenboom P (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer’s disease and control brain. Acta Neuropathol 101:2–8. Google Scholar
  117. Hosnedlova B, Kepinska M, Skalickova S, Fernandez C, Ruttkay-Nedecky B, Peng Q, Baron M, Melcova M, Opatrilova R, Zidkova J, Bjørklund G, Sochor J, Kizek R (2018) Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomedicine 13:2107–2128. Google Scholar
  118. Hrdina P, Peters D, Singhal R (1976) Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat. Res Commun Chem Pathol Pharmacol 15:483–493Google Scholar
  119. Iqbal K, Gong C-X, Liu F (2014) Microtubule-associated protein tau as a therapeutic target in Alzheimer’s disease. Expert Opin Ther Targets 18:307–318. Google Scholar
  120. Islam MZ, Van Dao C, Shiraishi M, Miyamoto A (2016) Methylmercury affects cerebrovascular reactivity to angiotensin II and acetylcholine via rho-kinase and nitric oxide pathways in mice. Life Sci 147:30–38. Google Scholar
  121. Ji X, Jin G, Qu L, Cheng J, Wang W (2006) Effect of chronic exposure by mercury contaminated rice on neurotransmitter level changes in rat brain (in Chinese). Huan Jing Ke Xue 27:142–145Google Scholar
  122. Juarez B, Martınez M, Montante M, Dufour L, Garcıa E, Jimenez-Capdeville M (2002) Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. Neurotoxicol Teratol 24:767–771. Google Scholar
  123. Kanda H, Shinkai Y, Kumagai Y (2014) S-Mercuration of cellular proteins by methylmercury and its toxicological implications. J Toxicol Sci 39:687–700. Google Scholar
  124. Keeney JT, Butterfield DA (2015) Vitamin D deficiency and Alzheimer disease: common links. Neurobiol Dis 84:84–98. Google Scholar
  125. Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR (2012) Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol Exp (Wars) 72:113–153Google Scholar
  126. Kern JK, Geier DA, Bjørklund G, King PG, Homme KG, Haley BE, Sykes LK, Geier MR (2014) Evidence supporting a link between dental amalgams and chronic illness, fatigue, depression, anxiety, and suicide. Neuroendocrinol Lett 35:535–552Google Scholar
  127. Kim DK, Park JD, Choi BS (2014) Mercury-induced amyloid-beta (Aβ) accumulation in the brain is mediated by disruption of Aβ transport. J Toxicol Sci 39:625–635. Google Scholar
  128. Kim SA, Kwon Y, Kim S, Joung H (2016) Assessment of dietary mercury intake and blood mercury levels in the Korean population: results from the Korean national environmental health survey 2012–2014. Int J Environ Res Public Health 13:877. Google Scholar
  129. Kim A, Lim S, Kim Y (2018) Metal ion effects on Aβ and tau aggregation. Int J Mol Sci 19:128. Google Scholar
  130. Korbas M, O'Donoghue JL, Watson GE, Pickering IJ, Singh SP, Myers GJ, Clarkson TW, George GN (2010) The chemical nature of mercury in human brain following poisoning or environmental exposure. ACS Chem Neurosci 1:810–818. Google Scholar
  131. Koseoglu E, Koseoglu R, Kendirci M, Saraymen R, Saraymen B (2017) Trace metal concentrations in hair and nails from Alzheimer’s disease patients: relations with clinical severity. J Trace Elem Med Biol 39:124–128. Google Scholar
  132. Kostka B, Krajewska U, Rieske P (1997) Platelet activation by mercuric compounds. Platelets 8:413–417. Google Scholar
  133. Kröger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D (2009) Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging. Am J Clin Nutr 90(1):184–192. Google Scholar
  134. Kruyer A, Soplop N, Strickland S, Norris EH (2015) Chronic hypertension leads to neurodegeneration in the TgSwDI mouse model of Alzheimer’s disease. Hypertension 66:175–182. Google Scholar
  135. Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA (2017) Association of antioxidant supplement use and dementia in the prevention of Alzheimer’s disease by vitamin E and selenium trial (PREADViSE). JAMA Neurol 74:567–573. Google Scholar
  136. Kumar SV, Bhattacharya S (2000) In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: influence of adenylate cyclase and phosphodiesterase activity. In Vitr Mol Toxicol 13:137–144Google Scholar
  137. Kumar G, Srivastava A, Sharma SK, Gupta YK (2014) Safety evaluation of mercury based Ayurvedic formulation (Sidh Makardhwaj) on brain cerebrum, liver & kidney in rats. Indian J Med Res 139:610Google Scholar
  138. Le Guennec K, Veugelen S, Quenez O, Szaruga M, Rousseau S, Nicolas G, Wallon D, Fluchere F, Frébourg T, De Strooper B (2017) Deletion of exons 9 and 10 of the presenilin 1 gene in a patient with early-onset Alzheimer disease generates longer amyloid seeds. Neurobiol Dis 104:97–103. Google Scholar
  139. Lee JY, Kim JH, Choi DW, Lee DW, Park JH, Yoon HJ, Pyo HS, Kwon HJ, Park KS (2012) The association of heavy metal of blood and serum in the Alzheimer’s diseases. Toxicol Res 28:93–98. Google Scholar
  140. Leong CC, Syed NI, Lorscheider FL (2001) Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 12:733–737. Google Scholar
  141. Li X, Long J, He T, Belshaw R, Scott J (2015) Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer’s disease. Sci Rep 5:12393. Google Scholar
  142. Liang J, Feng C, Zeng G, Zhong M, Gao X, Li X, He X, Li X, Fang Y, Mo D (2017) Atmospheric deposition of mercury and cadmium impacts on topsoil in a typical coal mine city, Lianyuan, China. Chemosphere 189:198–205. Google Scholar
  143. Lim K-M, Kim S, Noh J-Y, Kim K, Jang W-H, Bae O-N, Chung S-M, Chung J-H (2010) Low-level mercury can enhance procoagulant activity of erythrocytes: a new contributing factor for mercury-related thrombotic disease. Environ Health Perspect 118:928. Google Scholar
  144. Liu W, Wang X, Zhang R, Zhou Y (2009) Effects of postnatal exposure to methylmercury on spatial learning and memory and brain NMDA receptor mRNA expression in rats. Toxicol Lett 188:230–235. Google Scholar
  145. Liu Y, Zhang W, Zhao J, Lin X, Liu J, Cui L, Gao Y, Zhang TL, Li B, Li YF (2018) Selenoprotein P as the major transporter for mercury in serum from methylmercury-poisoned rats. J Trace Elem Med Biol 50:589–595. Google Scholar
  146. Lombardo S, Maskos U (2015) Role of the nicotinic acetylcholine receptor in Alzheimer’s disease pathology and treatment. Neuropharmacology 96:255–262. Google Scholar
  147. MacKenzie IR (1996) Serum trace metals in patients with “Alzheimer-type” senile plaques. Trace Elem Electrolytes 13:107–108Google Scholar
  148. Maximino C, Araujo J, Leão LKR, Grisolia ABA, Oliveira KRM, Lima MG, Batista EJO, Crespo-López ME, Gouveia A Jr, Herculano AM (2011) Possible role of serotoninergic system in the neurobehavioral impairment induced by acute methylmercury exposure in zebrafish (Danio rerio). Neurotoxicol Teratol 33:727–734. Google Scholar
  149. McHuron EA, Peterson SH, Ackerman JT, Melin SR, Harris JD, Costa DP (2016) Effects of age, colony, and sex on mercury concentrations in California sea lions. Arch Environ Contam Toxicol 70:46–55. Google Scholar
  150. Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol 6:37. Google Scholar
  151. Miller TJ, Grow WA (2004) Mercury decreases the frequency of induced but not spontaneous clustering of acetylcholine receptors. Cell Tissue Res 316:211–219. Google Scholar
  152. Mirzoian A, Luetje CW (2002) Modulation of neuronal nicotinic acetylcholine receptors by mercury. J Pharmacol Exp Ther 302:560–567. Google Scholar
  153. Miyamoto K, Nakanishi H, Moriguchi S, Fukuyama N, Eto K, Wakamiya J, Murao K, Arimura K, Osame M (2001) Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity. Brain Research 901(1-2):252–258Google Scholar
  154. Monnet-Tschudi F, Zurich M-G, Boschat C, Corbaz A, Honegger P (2006) Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 21:105–118. Google Scholar
  155. Moreira MJS, Schwertner C, Jardim JJ, Hashizume LN (2016) Dental caries in individuals with D own syndrome: a systematic review. Int J Paediatr Dent 26:3–12. Google Scholar
  156. Moretto MB, Lermen CL, Morsch VM, Bohrer D, Ineu RP, da Silva AC, Balz D, Schetinger MRC (2004) Effect of subchronic treatment with mercury chloride on NTPDase, 5′-nucleotidase and acetylcholinesterase from cerebral cortex of rats. J Trace Elem Med Biol 17:255–260. Google Scholar
  157. Moretto M, Funchal C, Santos A, Gottfried C, Boff B, Zeni G, Pessoa-Pureur R, Souza D, Wofchuk S, Rocha J (2005) Ebselen protects glutamate uptake inhibition caused by methyl mercury but does not by Hg2+. Toxicology 214:57–66. Google Scholar
  158. Morris MC, Brockman J, Schneider JA, Wang Y, Bennett DA, Tangney CC, van de Rest O (2016) Association of seafood consumption, brain mercury level, and APOE ε4 status with brain neuropathology in older adults. JAMA 315:489–497. Google Scholar
  159. Mortazavi S, Neghab M, Anoosheh S, Bahaeddini N, Mortazavi G, Neghab P, Rajaeifard A (2014) High-field MRI and mercury release from dental amalgam fillings. Int J Occup Environ Med 5:316-101-315Google Scholar
  160. Mutkus L, Aschner JL, Syversen T, Aschner M (2005) Methylmercury alters the in vitro uptake of glutamate in GLAST-and GLT-1-transfected mutant CHO-K1 cells. Biol Trace Elem Res 107:231–245. Google Scholar
  161. Mutter J, Curth A, Naumann J, Deth R, Walach H (2010) Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis 22:357–374. Google Scholar
  162. Nakazawa K, Nagafuchi O, Kawakami T, Inoue T, Yokota K, Serikawa Y, Cyio B, Elvince R (2016) Human health risk assessment of mercury vapor around artisanal small-scale gold mining area, Palu city, Central Sulawesi, Indonesia. Ecotoxicol Environ Saf 124:155–162. Google Scholar
  163. Natalello A, Relini A, Penco A, Halabelian L, Bolognesi M, Doglia SM, Ricagno S (2015) Wild type beta-2 microglobulin and DE loop mutants display a common fibrillar architecture. PLoS One 10:e0122449. Google Scholar
  164. Nazıroğlu M, Muhamad S, Pecze L (2017) Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles. Expert Rev Clin Pharmacol 10:773–782. Google Scholar
  165. Ndountse LT, Chan HM (2008) Methylmercury increases N-methyl-D-aspartate receptors on human SH-SY 5Y neuroblastoma cells leading to neurotoxicity. Toxicology 249:251–255. Google Scholar
  166. Ng S, Lin C-C, Hwang Y-H, Hsieh W-S, Liao H-F, Chen P-C (2013) Mercury, APOE, and children’s neurodevelopment. Neurotoxicology 37:85–92. Google Scholar
  167. NIH - National Institutes of Health (2018) APP gene: amyloid beta precursor protein. Genetics Home Reference. Accessed 16 December 2018
  168. Nylander M, Friberg L, Lind B (1987) Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 11:179–187Google Scholar
  169. Olcott MC, Bradley ML, Haley BE (1994) Photoaffinity labeling of creatine kinase with 2-azido-and 8-azidoadenosine triphosphate: identification of two peptides from the ATP-binding domain. Biochemistry 33:11935–11941. Google Scholar
  170. Olivieri G, Brack C, Müller-Spahn F, Stähelin H, Herrmann M, Renard P, Brockhaus M, Hock C (2000) Mercury induces cell cytotoxicity and oxidative stress and increases β-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem 74:231–236. Google Scholar
  171. Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Müller-Spahn F (2002) The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion. Neuroscience 113:849–855. Google Scholar
  172. Osuntokun BO, Sahota A, Ogunniyi A, Gureje O, Baiyewu O, Adeyinka A, Oluwole S, Komolafe O, Hall K, Unverzagt F (1995) Lack of an association between apolipoprotein E ϵ4 and Alzheimer’s disease in elderly. Nigerians Ann Neurol 38:463–465. Google Scholar
  173. Oudar P, Caillard L, Fillion G (1989) In vitro effect of organic and inorganic mercury on the serotonergic system. Pharmacol Toxicol 65:245–248. Google Scholar
  174. Paglia G, Miedico O, Cristofano A, Vitale M, Angiolillo A, Chiaravalle AE, Corso G, Di Costanzo A (2016) Distinctive pattern of serum elements during the progression of Alzheimer’s disease. Sci Rep 6:22769. Google Scholar
  175. Pamphlett R, Kum Jew S (2015) Different populations of human locus ceruleus neurons contain heavy metals or hyperphosphorylated tau: implications for amyloid-β and tau pathology in Alzheimer’s disease. J Alzheimers Dis 45:437–447. Google Scholar
  176. Papadopoulos P, Tong X-K, Imboden H, Hamel E (2017) Losartan improves cerebrovascular function in a mouse model of Alzheimer’s disease with combined overproduction of amyloid-β and transforming growth factor-β1. J Cereb Blood Flow Metab 37:1959–1970. Google Scholar
  177. Park HJ, Youn HS (2013) Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase. Toxicol Ind Health 29:169–174. Google Scholar
  178. Park JH, Lee DW, Park KS, Joung H (2014) Serum trace metal levels in Alzheimer’s disease and normal control groups. Am J Alzheimers Dis Other Demen 29:76–83. Google Scholar
  179. Parsons CG, Stoffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system—too little activation is bad, too much is even worse. Neuropharmacology 53:699–723. Google Scholar
  180. Pendergrass J, Haley B (1997) Inhibition of brain tubulin-guanosine 5′-triphosphate interactions by mercury: similarity to observations in Alzheimer’s diseased brain. Met Ions Biol Syst 34:461–478Google Scholar
  181. Petroni D, Tsai J, Agrawal K, Mondal D, George W (2012) Low-dose methylmercury-induced oxidative stress, cytotoxicity, and tau-hyperphosphorylation in human neuroblastoma (SH-SY5Y) cells. Environ Toxicol 27:549–555. Google Scholar
  182. Petroni D, Tsai J, Mondal D, George W (2013) Attenuation of low dose methylmercury and glutamate induced-cytotoxicity and tau phosphorylation by an N-methyl-D-aspartate antagonist in human neuroblastoma (SHSY5Y) cells. Environ Toxicol 28:700–706. Google Scholar
  183. Pigatto PD, Costa A, Guzzi G (2018) Are mercury and Alzheimer’s disease linked? Sci Total Environ 613:1579–1580. Google Scholar
  184. Pivovarova NB, Andrews SB (2010) Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J 277:3622–3636. Google Scholar
  185. Rasinger JD, Lundebye AK, Penglase SJ, Ellingsen S, Amlund H (2017) Methylmercury induced neurotoxicity and the influence of selenium in the brains of adult zebrafish (Danio rerio). Int J Mol Sci Mar 18:725. Google Scholar
  186. Raven F, Ward JF, Zoltowska KM, Wan Y, Bylykbashi E, Miller SJ, Shen X, Choi SH, Rynearson KD, Berezovska O (2017) Soluble gamma-secretase modulators attenuate Alzheimer’s β-amyloid pathology and induce conformational changes in presenilin 1. EBioMedicine 24:93–101. Google Scholar
  187. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7:137. Google Scholar
  188. Ren MY, Yang LY, Wang LF, Han XM, Dai JR, Pang XG (2018) Spatial trends and pollution assessment for mercury in the surface soils of the Nansi Lake catchment, China. Environ Sci Pollut Res Int 25:2417–2424. Google Scholar
  189. Richetti SK, Rosemberg DB, Ventura-Lima J, Monserrat JM, Bogo MR, Bonan CD (2011) Acetylcholinesterase activity and antioxidant capacity of zebrafish brain is altered by heavy metal exposure. Neurotoxicology 32:116–122. Google Scholar
  190. Rooney JP (2007) The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 234:145–156. Google Scholar
  191. Rooney JP (2014) The retention time of inorganic mercury in the brain—a systematic review of the evidence. Toxicol Appl Pharmacol 274:425–435. Google Scholar
  192. Roses AD (1998) Apolipoprotein E and Alzheimer’s disease: the tip of the susceptibility iceberg. Ann N Y Acad Sci 855:738–743. Google Scholar
  193. Rubinsztein D, Hon J, Stevens F, Pyrah I, Tysoe C, Huppert F, Easton D, Holland A (1999) Apo E genotypes and risk of dementia in Down syndrome. Am J Med Genet 88:344–347.<344::AID-AJMG10>3.0.CO;2-1 Google Scholar
  194. Rusina R, Matěj R, Kašparová L, Kukal J, Urban P (2011) Higher aluminum concentration in Alzheimer’s disease after Box-Cox data transformation. Neurotox Res 20(4):329–333. Google Scholar
  195. Russell SL (2017) Four or more amalgam fillings correlate with higher blood mercury levels in pregnant women but not high enough to be of health concern. J Evid Based Dent Pract 17:139–141. Google Scholar
  196. Sacuiu S, Insel PS, Mueller S, Tosun D, Mattsson N, Jack CR Jr, DeCarli C, Petersen R, Aisen PS, Weiner MW (2016) Chronic depressive symptomatology in mild cognitive impairment is associated with frontal atrophy rate which hastens conversion to Alzheimer dementia. Am J Geriatr Psychiatry 24:126–135. Google Scholar
  197. Sadleir KR, Kandalepas PC, Buggia-Prévot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. Acta Neuropathol 132:235–256. Google Scholar
  198. Salinaro AT, Pennisi M, Di Paola R, Scuto M, Crupi R, Cambria MT, Ontario ML, Tomasello M, Uva M, Maiolino L (2018) Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun Ageing 15:8. Google Scholar
  199. Samir AM, Aref WM (2011) Impact of occupational exposure to elemental mercury on some antioxidative enzymes among dental staff. Toxicol Ind Health 27:779–786. Google Scholar
  200. Samudralwar DL, Diprete CC, Ni BF, Ehmann WD, Markesbery WR (1995) Elemental imbalances in the olfactory pathway in Alzheimer’s disease. J Neurol Sci 130:139–145. Google Scholar
  201. Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, Cornett CR, Snowdon DA, Grant FT, Schmitt FA, Donegan SJ, Wekstein DR, Ehmann WD, Markesbery WR (1999) Alzheimer’s disease, dental amalgam and mercury. J Am Dent Assoc 130:191–199. Google Scholar
  202. Schousboe A (2017) A tribute to Mary C. McKenna: glutamate as energy substrate and neurotransmitter—functional interaction between neurons and astrocytes. Neurochem Res 42:4–9. Google Scholar
  203. Shahar A, Patel KV, Semba RD, Bandinelli S, Shahar DR, Ferrucci L, Guralnik JM (2010) Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed. Mov Disord 25:1909–1915. Google Scholar
  204. Sharman MJ, Gyengesi E, Liang H, Chatterjee P, Karl T, Li QX, Wenk MR, Halliwell B, Martins RN, Münch G (2019) Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer’s disease: are combinations more effective? Neurobiol Dis 124:505–519. Google Scholar
  205. Skalny AV, Skalnaya MG, Nikonorov AA, Tinkov AA (2016) Selenium antagonism with mercury and arsenic: from chemistry to population health and demography. In: selenium. Springer, Cham, pp 401–412Google Scholar
  206. Solovyev N, Drobyshev E, Bjørklund G, Dubrovskii Y, Lysiuk R, Rayman MP (2018) Selenium, selenoprotein P, and Alzheimer’s disease: is there a link? Free Radic Biol Med 127:124–133. Google Scholar
  207. Somavarapu AK, Kepp KP (2016) Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer’s disease. J Neurochem 137:101–111. Google Scholar
  208. Song JW, Choi BS (2013) Mercury induced the accumulation of amyloid beta (Aβ) in PC12 cells: the role of production and degradation of Aβ. Toxicol Res 29:235Google Scholar
  209. Sonkar VK, Kulkarni PP, Dash D (2014) Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization. FASEB J 28:1819–1829. Google Scholar
  210. Spiller HA (2018) Rethinking mercury: the role of selenium in the pathophysiology of mercury toxicity. Clin Toxicol 56:313–326. Google Scholar
  211. Streets DG, Lu Z, Levin L, ter Schure AF, Sunderland EM (2018) Historical releases of mercury to air, land, and water from coal combustion. Sci Total Environ 615:131–140. Google Scholar
  212. Sun YH, Nfor ON, Huang JY, Liaw YP (2015) Association between dental amalgam fillings and Alzheimer’s disease: a population-based cross-sectional study in Taiwan Alzheimers. Res Ther 7:65. Google Scholar
  213. Syversen T, Kaur P (2012) The toxicology of mercury and its compounds. J Trace Elem Med Biol 26:215–226. Google Scholar
  214. Szabo ST, Harry GJ, Hayden KM, Szabo DT, Birnbaum L (2015) Comparison of metal levels between postmortem brain and ventricular fluid in Alzheimer’s disease and nondemented elderly controls. Toxicol Sci 150:292–300. Google Scholar
  215. Tabaton M, Tamagno E (2007) The molecular link between β-and γ-secretase activity on the amyloid β precursor protein. Cell Mol Life Sci 64:2211–2218. Google Scholar
  216. Tajeddinn W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, Kehr J, Shahnaz T, Milovanovic M, Behbahani H, Höglund K, Winblad B, Cedazo-Minguez A, Jelic V, Järemo P, Aarsland D (2016) Association of platelet serotonin levels in Alzheimer’s disease with clinical and cerebrospinal fluid markers. J Alzheimers Dis 53:621–630. Google Scholar
  217. Talesa VN (2001) Acetylcholinesterase in Alzheimer’s disease. Mech Ageing Dev 122:1961–1969. Google Scholar
  218. Thompson C, Markesbery W, Ehmann W, Mao Y, Vance D (1988) Regional brain trace-element studies in Alzheimer’s disease. Neurotoxicology 9:1–7Google Scholar
  219. Toimela T, Tähti H (2004) Mitochondrial viability and apoptosis induced by aluminum, mercuric mercury and methylmercury in cell lines of neural origin. Arch Toxicol 78:565–574. Google Scholar
  220. Tolonen M, Halme M, Sarna S (1985) Vitamin E and selenium supplementation in geriatric patients. Biol Trace Elem Res 7:161. Google Scholar
  221. Tratnik JS, Falnoga I, Trdin A, Mazej D, Fajon V, Miklavčič A, Kobal AB, Osredkar J, Briški AS, Krsnik M (2017) Prenatal mercury exposure, neurodevelopment and apolipoprotein E genetic polymorphism. Environ Res 152:375–385. Google Scholar
  222. Tsai C-L, Jang T-H, Wang L-H (1995) Effects of mercury on serotonin concentration in the brain of tilapia, Oreochromis mossambicus. Neurosci Lett 184:208–211. Google Scholar
  223. Uki M, Narahashi T (1996) Modulation of serotonin-induced currents by metals in mouse neuroblastoma cells. Arch Toxicol 70:652–660. Google Scholar
  224. Vance DE, Ehmann WD, Markesbery WR (1988) Trace element imbalances in hair and nails of Alzheimer's disease patients. Neurotoxicology 9:197–208.Google Scholar
  225. Varma VR, Varma S, An Y, Hohman TJ, Seddighi S, Casanova R, Beri A, Dammer EB, Seyfried NT, Pletnikova O (2017) Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry 22:13. Google Scholar
  226. Vassar R, Kovacs DM, Yan R, Wong PC (2009) The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 29:12787–12794. Google Scholar
  227. Vejrup K, Brantsæter AL, Knutsen HK, Magnus P, Alexander J, Kvalem HE, Meltzer HM, Haugen M (2014) Prenatal mercury exposure and infant birth weight in the Norwegian mother and child cohort study. Public Health Nutr 17:2071–2080. Google Scholar
  228. Walach H, Mutter J, Deth R (2015) Inorganic mercury and Alzheimer’s disease—results of a review and a molecular mechanism. In: Martin CR, Preedy VR (eds) Diet and Nutrition in Dementia and Cognitive Decline. Elsevier, Amsterdam, pp 593–601.
  229. Wallace TL, Bertrand D (2013) Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochem Pharmacol 85:1713–1720. Google Scholar
  230. Wang Q, Yang X, Zhang B, Yang X, Wang K (2013) Cinnabar is different from mercuric chloride in mercury absorption and influence on the brain serotonin level. Basic Clin Pharmacol Toxicol 112:412–417. Google Scholar
  231. Ward NI, Mason JA (1987) Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Chem 113: 515–526.
  232. Warfvinge K, Hansson H, Hultman P (1995) Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol 132:299–309. Google Scholar
  233. Wenstrup D, Ehmann WD, Markesbery WR (1990) Trace element imbalances in isolated subcellular fractions of Alzheimer’s disease. Brain Res 533:125–131Google Scholar
  234. Williams DR, Gonzalez HM, Neighbors H, Nesse R, Abelson JM, Sweetman J, Jackson JS (2007) Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American life. Arch Gen Psychiatry 64:305–315Google Scholar
  235. Wiseman FK, Al-Janabi T, Hardy J, Karmiloff-Smith A, Nizetic D, Tybulewicz VL, Fisher EM, Strydom A (2015) A genetic cause of Alzheimer disease: mechanistic insights from down syndrome. Nat Rev Neurosci 16:564. Google Scholar
  236. Xia D, Watanabe H, Wu B, Lee SH, Li Y, Tsvetkov E, Bolshakov VY, Shen J, Kelleher RJ (2015) Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer’s disease. Neuron 85:967–981. Google Scholar
  237. Xu F, Farkas S, Kortbeek S, Zhang F-X, Chen L, Zamponi GW, Syed NI (2012) Mercury-induced toxicity of rat cortical neurons is mediated through N-methyl-D-aspartate receptors. Mol Brain 5:30. Google Scholar
  238. Yamamoto M, Khan N, Muniroh M, Motomura E, Yanagisawa R, Matsuyama T, Vogel CF (2017) Activation of interleukin-6 and-8 expressions by methylmercury in human U937 macrophages involves RelA and p50. J Appl Toxicol 37:611–620. Google Scholar
  239. Yan R, Vassar R (2014) Targeting the β secretase BACE1 for Alzheimer’s disease therapy. Lancet Neurol 13:319–329. Google Scholar
  240. Yang DJ, Shi S, Zheng LF, Yao TM, Ji LN (2010) Mercury (II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: coordination and conformational transition. Biopolymers 93:1100–1107. Google Scholar
  241. Yang DJ, Shi S, Yao TM, Ji LN (2011) The impacts of Hg (II) tightly binding on the Alzheimer’s tau construct R3: misfolding and aggregation. Bull Chem Soc Jpn 84:1362–1367. Google Scholar
  242. Yang H, Turner S, Rose NL (2016) Mercury pollution in the lake sediments and catchment soils of anthropogenically-disturbed sites across England. Environ Pollut 219:1092–1101. Google Scholar
  243. Yang YW, Liou SH, Hsueh YM, Lyu WS, Liu CS, Liu HJ, Chung MC, Hung PH, Chung CJ (2018) Risk of Alzheimer’s disease with metal concentrations in whole blood and urine: a case-control study using propensity score matching. Toxicol Appl Pharmacol 356:8–14. Google Scholar
  244. Yao K, Li Y, Zhu X, Zhu L (2014) Individual and joint effects of lead and mercury on acetylcholinesterase activity in goldfish brain. Fresenius Environ Bull 23:2514–2519Google Scholar
  245. Yin L, Yu K, Lin S, Song X, Yu X (2016) Associations of blood mercury, inorganic mercury, methyl mercury and bisphenol a with dental surface restorations in the US population, NHANES 2003–2004 and 2010–2012. Ecotoxicol Environ Saf 134:213–225. Google Scholar
  246. Ynalvez R, Gutierrez J, Gonzalez-Cantu H (2016) Mini-review: toxicity of mercury as a consequence of enzyme alteration. Biometals 29:781–788. Google Scholar
  247. Yousuf FA, Iqbal MP (2015) Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations. Pak J Pharm Sci 28Google Scholar
  248. Zhang S, Rocourt C, Cheng WH (2010) Selenoproteins and the aging brain. Mech Ageing Dev 131:253–260. Google Scholar
  249. Zhou Y, Aamir M, Liu K, Yang F, Liu W (2018) Status of mercury accumulation in agricultural soil across China: spatial distribution, temporal trend, influencing factor and risk assessment. Environ Pollut Sep 240:116–124. Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Geir Bjørklund
    • 1
    Email author
  • Alexey A. Tinkov
    • 2
    • 3
    • 4
  • Maryam Dadar
    • 5
  • Md. Mostafizur Rahman
    • 6
    • 7
  • Salvatore Chirumbolo
    • 8
  • Anatoly V. Skalny
    • 3
    • 4
    • 9
  • Margarita G. Skalnaya
    • 3
    • 4
  • Boyd E. Haley
    • 10
  • Olga P. Ajsuvakova
    • 2
    • 3
    • 4
  • Jan Aaseth
    • 11
    • 12
  1. 1.Council for Nutritional and Environmental MedicineMo i RanaNorway
  2. 2.Yaroslavl State UniversityYaroslavlRussia
  3. 3.Peoples’ Friendship University of Russia (RUDN University)MoscowRussia
  4. 4.IM Sechenov First Moscow State Medical UniversityMoscowRussia
  5. 5.Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO)KarajIran
  6. 6.Department of Environmental SciencesJahangirnagar UniversityDhakaBangladesh
  7. 7.Graduate School of Environmental ScienceHokkaido UniversitySapporoJapan
  8. 8.Department of Neuroscience, Biomedicine and Movement SciencesUniversity of VeronaVeronaItaly
  9. 9.Federal Research Centre of Biological Systems and Agro-technologies of the Russian Academy of SciencesOrenburgRussia
  10. 10.University of KentuckyLexingtonUSA
  11. 11.Research Department, Innlandet Hospital TrustBrumunddalNorway
  12. 12.Inland Norway University of Applied SciencesElverumNorway

Personalised recommendations